Testing Experimental Medication in Healthy Subjects
Study Description
“A Study of LY3463251 in Healthy Participants”
The purpose of this study is to evaluate the safety and tolerability (side effects) of single (Part A) and multiple (Part B) doses of the study drug when it is administered subcutaneously (under the skin) into the abdomen. This is a two-part study. Participants will enroll in only one part. For each participant, Part A will last about 10 weeks and Part B will last about 23 weeks, including screening.
Location
Methods
Pharmaceutical medication involved
Patients and healthy individuals accepted
Drug - LY3463251
Administered SC
Drug - Placebo
Administered SC
Additional Information
Official Study Title
A Randomized, Placebo-Controlled, Subject- and Investigator-Blind, Single and Multiple Dose, Safety, Tolerability, and Pharmacokinetics Study of LY3463251 in Healthy and Overweight Healthy Subjects
Clinical Trial ID
NCT03764774
ParticipAid ID
aKr5re
